http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015523986-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
| filingDate | 2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015523986-A |
| titleOfInvention | Treatment of ocular inflammatory diseases using laquinimod |
| abstract | Disclosed is a method for treating ocular inflammatory disease (OID), such as uveitis or conjunctivitis, comprising periodically administering a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt thereof. Is done. Laquinimod or pharmaceutically for use in the treatment of subjects suffering from inflammation of OID, uveitis, bacterial conjunctivitis, viral conjunctivitis, orbital tissue, lacrimal organs, eyelids, cornea, retina, or optic tract Also provided is a pharmaceutical composition comprising an acceptable salt thereof. The application also provides a method for treating a subject suffering from ocular inflammation associated with an autoimmune disease, wherein a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt is administered to the subject on a regular basis. And ophthalmic pharmaceutical compositions comprising laquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of ocular inflammation associated with autoimmune diseases. |
| priorityDate | 2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.